LIFE Biosystems GmbH announced today that it has entered into a collaborative agreement with the Department of Bioinformatics at the Fraunhofer Institute for Algorithms and Scientific Computing SCAI.
As part of this agreement, LIFE has licensed the ProMiner entity recognition software, which will become an integral part of LIFE's text-mining infrastructure. In addition, both parties will work to collaboratively advance the development of information extraction algorithms in the clinical research domain. These efforts will focus on the identification and modelling of therapeutically relevant information from clinical/lexical data, with particular emphasis on drug mode of action and clinical outcomes.
"We have been extremely impressed by the advances made by SCAI in the field of biological information extraction" stated Dr. David Jackson, Director of in silico Discovery at LIFE Biosystems. "The synergies created as a result of this collaboration will enable us to efficiently bridge the gap between the clinical and molecular information domains. In so doing, we aim to achieve a new level of innovation in the analysis and application of patient derived data".
"The collaboration with LIFE Biosystems fits perfectly with our overall strategy to further develop our text-mining technologies for application areas beyond biology" says Dr. Juliane Fluck, Head of the Text Mining Group at Fraunhofer SCAI. "The domain of clinical information requires dedicated solutions for information extraction and the collaboration with LIFE Biosystems will help us to develop specialized ProMiner functionalities supporting mining in unstructured clinical data".
ABOUT LIFE BIOSYSTEMSLIFE Biosystems is an in silico-driven discovery company dedicated to the field of predictive medicine. Working together the biopharmaceutical industry and comprehensive cancer centers, we strive to address the key issues facing clinical research and therapeutic development today. As expert practitioners of in silico discovery in molecular medicine, our goal is to transform patient information and molecular data into a new level of clinical discovery, intellectual property and ultimately, patient benefit. For additional information about the company, please visit:
Decision-making research in children: Rules of thumb are learned with time
19.10.2016 | Max-Planck-Institut für Bildungsforschung
Young people discover the "Learning Center"
20.09.2016 | Research Center Pharmaceutical Engineering GmbH
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences